Overview of FDA's Expanded Access Program (13/14) REdI 2017

J. Paul Phillips provides an overview of the FDA’s expanded access program with a focus on investigational drug and biological products. The program’s role in providing patients treatment access to these products as well
as the regulatory foundation for the program is discussed. The presentation identifies the types of expanded access requests and the criteria that must be met to allow authorization of those requests.

-------------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia

CDER SBIA 2017 Playlist:    • 2017 CDER Small Business and Industry...  
LinkedIn:   / cder-small-business-and-industry-assistance  
Training resources: https://www.fda.gov/cderbsbialearn

Twitter:   / fda_drug_info  

CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367